– USA, NY – Trellus Health plc (LON: TRLS), a health services company delivering innovative, scientifically validated programs and technologies designed to facilitate the management of chronic conditions, improve health outcomes, and lower the costs of care, announced the appointment of Kevin Murphy to its Board as an Independent Non-executive Director, effective immediately, and as Chair-designate, to replace Dr. Daniel Mahony as Chair, after AGM on 14 June 2024.
About Kevin L. Murphy Jr.
Kevin Murphy is an experienced healthcare executive, having worked as a P&L leader for both large and small organizations in the healthcare, insurance, and pharmacy industries. Kevin’s expertise includes strategy development and execution, clinical program delivery, driving revenue and margin expansion, acquisitions, integrations, joint ventures, and new product and market /commercial development.
Kevin recently retired from CVS Health Corporation, a Fortune 500 healthcare company providing advanced health care from pharmacy services and health plans, to health and wellness. At CVS Health, he spent over ten years in various roles. Kevin joined CVS Health as President of Accordant, which delivers personalized healthcare advice to members and their caregivers through the support of nurse teams and support staff, while reducing overall healthcare costs. There, he led a significant turnaround which included reorganizing the clinical care delivery model, upgrading Accordant’s core operating systems, and opening new markets and distribution channels, resulting in an increase in revenues and EBIT. Subsequently, Kevin spent five years as Group Head of Specialty and Infusion at CVS Health, which included negotiating and acting as business lead for the $2.1B acquisition of Coram; in 2019, Kevin was appointed SVP, Payer Relations, and Managed Care.
Before joining CVS Health, Kevin held P&L leadership roles at Medco, the largest pharmacy benefits management company in the US, and Physicians Health Services, a regional health insurance group.
Kevin graduated with a B.S. in Management from the University of Rhode Island and an M.S. in Finance from Fairfield University.
About Trellus Health plc
Trellus Health is a health services company providing value-based innovative solutions and services for chronic condition management that prioritizes improved outcomes and member experiences while managing costs of care.
Trellus Health integrates its proprietary resilience-based methodology with the technology, tools, and expert coaching and educator team to deliver Trellus Elevate, a whole-person technology-enhanced experience that meets each individual’s unique needs and empowers them to master their physical and emotional health. Trellus Elevate’s clinically proven solutions result in relieving disease burden, building self-management skills, and promoting positive health behaviors that improve outcomes and enable thriving in the face of a chronic condition.
The Company’s proven whole-person approach recognizes the interconnectedness of various aspects of a person’s life and aims to address the whole spectrum of factors that influence behavior, to promote comprehensive well-being and human flourishing in a way that aligns with value-based care. Trellus Health’s approach enables better health outcomes in a member-centric, personalized, and comprehensive holistic solution.
The Company was founded by Mount Sinai faculty members Marla C. Dubinsky, MD, and Laurie Keefer, PhD, both experts at treating and healing both the physical and emotional impacts of IBD and have been innovators for whole-person healthcare for a combined 50 years.
The Company is initially focusing on chronic costly GI conditions that have a high mental health burden, such as inflammatory bowel disease which includes the chronic incurable conditions of Crohn’s Disease and ulcerative colitis. Given the common emotional and mental health struggles often experienced by individuals suffering from a variety of chronic conditions, Trellus Health considers its approach to have potential utility and demand across many conditions.
The Trellus Elevate program incorporates the GRITT methodology and learnings on resilience from clinical research and practice conducted at the Mount Sinai IBD Center for more than seven years. This proprietary, resilience-driven methodology has been scientifically validated to demonstrate meaningful improvements in patient outcomes, a 71% reduction in Emergency Department (A&E) visits, and a 94% reduction in unplanned hospitalizations, which the directors of the Company believe indicates the potential for significant cost savings for healthcare payers and health systems. Patients with IBD managed with the proprietary resilience methodology also experienced a 49% reduction in required opioid use and a 73% reduction in corticosteroid use 12 months following starting the program which is a major indicator of improved health outcomes.
For more information: https://trellushealth.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.